pramipexole has been researched along with Dizzyness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M | 1 |
| Culhane, M; Evins, AE; Frank, MJ; Pajtas, PE; Pizzagalli, DA; Santesso, DL; Schetter, EC | 1 |
1 trial(s) available for pramipexole and Dizzyness
| Article | Year |
|---|---|
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness.
Topics: Administration, Oral; Adult; Age Factors; Algorithms; Association Learning; Behavior; Benzothiazoles; Blood Pressure; Chi-Square Distribution; Discrimination Learning; Dizziness; Double-Blind Method; Female; Humans; Male; Nausea; Pramipexole; Reaction Time; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement Schedule; Reward; Sex Factors | 2008 |
1 other study(ies) available for pramipexole and Dizzyness
| Article | Year |
|---|---|
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors | 2012 |